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AbstrAct
Objectives We conducted an individual participant 
meta-analysis to test the hypothesis that cortisol patterns 
indicative of dysregulated hypothalamic–pituitary–adrenal 
axis functioning would be prospectively associated with 
poorer well-being at follow-up.
setting Four large UK-based cohort studies.
Participants Those providing valid salivary or serum 
cortisol samples (n=7515 for morning cortisol; n=1612 
for cortisol awakening response) at baseline (age 44–82) 
and well-being data on the Warwick Edinburgh Mental 
Wellbeing Scale at follow-up (0–8 years) were included.
results Well-being was not associated with morning 
cortisol, diurnal slope or awakening response though a 
borderline association with evening cortisol was found. 
Adjusting for sex and follow-up time, each 1 SD increase 
in evening cortisol was associated with a −0.47 (95% 
CI −1.00 to 0.05) point lower well-being. This was 
attenuated by adjustment for body mass index, smoking 
and socioeconomic position. Between-study heterogeneity 
was low.
conclusions This study does not support the hypothesis 
that diurnal cortisol is prospectively associated with 
well-being up to 8 years later. However, replication in 
prospective studies with cortisol samples over multiple 
days is required.
IntrOductIOn
Cortisol is a marker of hypothalamic–pitu-
itary–adrenal (HPA) axis functioning and 
follows a diurnal rhythm. Large-scale epide-
miological studies have measured salivary 
cortisol sampled several times during the 
course of a day to capture its rising levels 
during the awakening response and the subse-
quent decline across the day. The mental 
health and well-being consequences of raised 
cortisol levels are of interest particularly 
among older people given that some studies 
find they have higher evening cortisol levels1 
and greater total cortisol output throughout 
the day2 compared with younger people 
though there is interindividual variation in 
age-related change in cortisol3 and this may 
reflect age-related change in disease rather 
than normal ageing.4
Positive mental well-being is a multidimen-
sional concept that captures hedonic (eg, 
happiness and experiencing pleasure) and 
eudaemonic (eg, self-realisation and psycho-
logically functioning at potential) aspects of 
mental health that are distinct from depres-
sive illness.5 Cortisol may be linked to a posi-
tive psychological state through its effect on 
mood-altering neurotransmitters including 
serotonin.6 Cortisol also has energy-mobil-
ising properties that may in turn promote 
mental well-being.7
Two studies of healthy older people found 
no association between cortisol levels and 
positive well-being (captured by the positive 
items of the General Health Questionnaire8 
or by daily positive emotions9). A study of 
women aged 65 and over found that greater 
eudaimonic well-being was associated with 
flatter cortisol slope over the day, though this 
was due to lower morning cortisol levels which 
remained low across the day.10 All studies 
were small (less than 200 participants). In 
younger adults (ie, 55 years and younger), 
some studies have found that greater positive 
affect or happiness was associated with lower 
total cortisol output11–14 but others have 
not.15 16 Greater optimism has also been asso-
ciated with a smaller awakening response.12
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strengths and limitations of this study
 ► Individual participant meta-analysis based on 1612–
7515 participants with cortisol data.
 ► Prospective study with up to 8 years of follow-up.
 ► Validated mental well-being instrument based 
on 14 items capturing hedonic and eudaemonic 
components harmonised across cohorts.
 ► Salivary cortisol samples taken over 1 or 2 days, up 
to a maximum of 4 times per day.
 ► Actual waking time was not recorded in all studies.
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These studies have not examined prospective asso-
ciations between baseline cortisol patterns and well-
being at follow-up in large, population-based samples. 
Although stressors are typically associated with HPA 
axis activation and decreases in vagal tone, some studies 
suggest that there may in some cases be a subsequent 
response involving the dorso-vagal parasympathetic 
system and downregulation of the HPA axis resulting in 
low cortisol levels.17 If this is the case, then a long-term 
inverse association between cortisol and well-being may 
not be evident.
The aim of the current study was to draw on individual 
participant data from four large British cohort studies 
using meta-analysis to examine the longitudinal asso-
ciations between diurnal cortisol and positive mental 
well-being captured by an instrument which summarises 
positive thoughts and feelings from both hedonic and 
eudaemonic perspectives. We hypothesised that cortisol 
patterns indicative of disrupted HPA axis functioning 
(ie, lower early morning levels, higher evening levels, 
less steep decline (ie, flatter response) across the day 
and larger awakening response) would be associated with 
lower well-being at follow-up.
MethOds
cohort studies
We used the four cohort studies from the Healthy Ageing 
across the Life Course cross-cohort research programme18 
with data on both cortisol and Warwick Edinburgh Mental 
Wellbeing Scale (WEMWBS): the Caerphilly Prospective 
Study (CaPS)19; the Hertfordshire Cohort Study (HCS)20; 
the Medical Research Council (MRC) National Survey 
of Health and Development (NSHD)21 and the National 
Child Development Study (NCDS).22 All studies received 
appropriate ethical approval.19–22
CaPS
CaPS is a cohort of men who were recruited when they 
were aged 45–59 years, between 1979 and 1983, from the 
town of Caerphilly and adjacent villages in South Wales. 
In the second wave (1984–1988) the original cohort was 
supplemented with men of a similar age who had moved 
into the defined area. Salivary cortisol was assessed at 
phase 5 of data collection in 2000–2004 when participants 
were aged 65 to 82 years and well-being was assessed in 
2011 when they were aged 73 to 90 years.
HCS
HCS is a cohort of men and women born in East, North 
or West Hertfordshire between 1931 and 1939 whose 
birth and infant records were available and who were 
alive and still living in Hertfordshire in the 1990s. Cortisol 
was assessed at wave 1 of the data collection (1999–2004) 
when participants were aged 60–73 years and well-being 
was assessed in 2008 when they were aged 69–78.
The MRC NSHD
National Survey of Health and Development (NSHD) 
is a nationally representative sample of people born in 
England, Scotland, and Wales during 1 week in March 
1946 followed prospectively since birth. Cortisol and 
well-being data were collected in 2008–10 when cohort 
members were aged 62–64 years.
The NCDS
NCDS is a nationally representative sample of people 
born in England, Scotland and Wales during 1 week in 
March 1958 followed prospectively since birth. Cortisol 
was assessed as part of a biomedical survey (2002–2004) 
when cohort members were aged 44–45 and well-being 
was assessed at a follow-up (2008–2009) at mean age of 
50.7.
cortisol
All study members who had not withdrawn or been lost to 
follow-up at the relevant sweep were invited to participate 
in the cortisol sampling. In HCS, one fasting morning 
serum cortisol sample was taken from each participant at 
a research clinic between 8:30 and 9:30 (the exact timing 
was not recorded), frozen and subsequently measured 
by radioimmunoassay. Salivary cortisol samples were 
collected in CaPS, NSHD and NCDS at multiple times 
across the day with participants shown how to collect 
saliva using plain cotton wool swabs (salivettes) at home. 
Subjects were asked to chew on the salivettes for 1–2 min 
and a saliva sample was obtained. In CaPS, participants 
were requested to take samples on waking, 30 min later, 
at 14:00 and 22:00 on two consecutive days. In NSHD, 
samples were taken on waking, 30 min later and at 21:00. 
Samples in NCDS were taken in the first 45 min after 
waking and 3 hours later. Samples from CaPS, NSHD and 
NCDS were frozen and subsequently assayed by radio-
immunoassay done at the University of Dresden which 
specialises in high throughput cortisol assays.23
Mental well-being
Positive mental well-being was assessed using WEMWBS 
in all four studies. This self-completion scale captures 
positive affect, satisfying interpersonal relationships 
and positive functioning. Items are worded positively 
and respondents are asked to indicate how frequently, 
on a five-point scale, they have experienced each state-
ment over the last 2 weeks. Statements include ‘I’ve been 
feeling good about myself’, ‘I’ve been feeling close to 
other people’, ‘I’ve been interested in new things’ and 
‘I’ve been feeling optimistic about the future’. Scores 
theoretically range from 14 to 70 with 70 indicating 
highest well-being. Where three or fewer items were 
missing, values were imputed based on the average score 
for completed items (CaPS n=43; HCS n=52; NSHD n=84; 
NCDS n=103). Internal consistency of the scale in all four 
cohorts was high (Cronbach alpha=0.91 in HCS, NSHD 
and NCDS and 0.93 in CaPS).24 Validation work indicates 
good construct validity for a single factor structure as well 
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as good criterion validity and test–retest reliability and 
supports its use in general population samples.25
covariates
Key covariates that might confound the association 
between cortisol and well-being and which had been 
assessed in each of the cohorts were chosen a priori: sex, 
age at cortisol measurement, follow-up time to measure-
ment of well-being, body mass index (BMI), smoking, 
and adult socio-economic position.26–28 The covariates 
were measured at the same wave as cortisol samples 
unless otherwise stated. BMI was calculated as measured 
weight divided by the square of height and was catego-
rised into quartiles when there was evidence of deviation 
from linearity in the association with well-being (NSHD, 
NCDS). Smoking was reported by participants and dichot-
omised into current smoker versus ex-smoker and never 
smoker (NCDS smoking data at age 42 years). Adult socio-
economic position was derived from own occupational 
class (CaPS at age 47–67, HCS at age 60–73, NSHD at age 
53 or earlier if missing, NCDS at age 42) and grouped as 
manual or non-manual occupation (the latter indicating 
greater socioeconomic advantage).
Initial treatment of the data and standardisation
Cortisol has a marked circadian rhythm and therefore 
the time of day at which it is sampled will affect its level. 
In CaPS, NSHD and NCDS actual times when the sali-
vary samples were taken were recorded by participants. 
Observed values were adjusted for the time of sampling 
by fitting a linear or polynomial function to the associ-
ation between cortisol and time of measurement and 
adding the resulting residuals from the best fit model to 
the overall mean cortisol value. This gives the estimated 
cortisol level at the time specified in the protocol for each 
participant. Morning cortisol (salivary or serum) levels 
were available in all four cohorts (CaPS, HCS, NSHD 
and NCDS) and night-time values in CaPS and NSHD. 
For NCDS, the later cortisol measure was taken 3 hours 
after the morning measure on the same day (around 
11:15) and there was no evening measure. However, 
past publications support the notion that the diurnal 
decline over this shorter period is a good surrogate for 
the decline from morning until night,29 and hence this 
measure was used to derive a measure of diurnal slope. 
HCS collected serum cortisol, the levels of which are 
around 20 times higher than the free cortisol concentra-
tions found in saliva. However, a study on the relationship 
between serum and salivary cortisol in healthy individ-
uals30 showed that correlations were high whether taken 
at the same time (>0.90) or 70 min apart (0.54—0.94). 
Those participants who reported taking corticosteroid 
medication were excluded from the analysis sample 
(CaPS n=62; HCS n=13; NSHD n=19). In NCDS, partici-
pants were excluded from analysis if they reported taking 
endocrine system medication (n=396). Outlying salivary 
cortisol values greater than 100 nmol/L were removed 
(CaPS n=5; NSHD n=7; NCDS n=21), since high cortisol 
values can have substantial statistical influence on esti-
mates and it is unclear what these high values represent.31 
Morning salivary cortisol values that were not between 
5:00 and noon were removed and evening values if they 
were before 20:00, since these participants with atypical 
sleeping hours may have substantially different cortisol 
profiles. In CaPS, cortisol values were averaged over the 
same measures obtained on two consecutive days. Early 
morning salivary cortisol was computed in CaPS and 
NSHD as the mean of waking and 30 min samples; to be 
comparable, in NCDS the cortisol measure taken within 
45 min after waking was used. In HCS, morning serum 
cortisol was used.
To be able to combine the cohorts in a meta-analysis, the 
cortisol values were standardised by deriving study-specific 
z-scores. In NCDS, both early and late morning cortisol 
were positively skewed, as was night-time cortisol in 
CaPS and NSHD, so values were loge transformed before 
they were converted to z-scores. In addition to the early 
morning and night-time cortisol measures, we derived 
the diurnal slope (CaPS, NSHD, NCDS) as early morning 
value subtracted from the evening (or late morning in 
NCDS) value and divided by the lapsed time period. The 
overall slope is negative and so positive z-scores indicate a 
flatter response. The cortisol awakening response (CAR) 
was derived as the difference between 30 min post-waking 
sample and the waking sample (CaPS, NSHD).
statistical methods
A two-stage meta-analysis was performed. In the first stage, 
we modelled WEMWBS as a function of each continuous 
diurnal cortisol indicator in turn using linear regression 
in each cohort separately, with adjustment for (1) sex, 
age at cortisol measurement and follow-up time to the 
well-being measurement, (2) additional adjustment for 
BMI, smoking status and socioeconomic position. There 
was no evidence of deviation from linearity in the associa-
tion between any of the cortisol measures and WEMWBS. 
There was no evidence of interaction between sex and 
any of the cortisol measures. In sensitivity analysis, to 
explore possible bias arising from missing covariates, we 
adjusted for sex and age at cortisol measurement and 
follow-up time (1) using the maximum available sample 
with cortisol and well-being data (results not presented), 
(2) using the sample restricted to only those participants 
that had complete data on all covariates. Results did not 
materially differ for these two samples. In the second 
stage, cohort-specific estimates were pooled in random-ef-
fects meta-analyses32 chosen a priori due to the expected 
heterogeneity between the different studies.
Sensitivity analyses
We corrected regression estimates for regression dilution 
bias arising from error in the measurement of cortisol. 
The reliability ratios were estimated by regressing the 
cortisol measure on day 2 on the measure on day 1 
from CaPS data.33 This yielded reliability ratios of 0.554, 
0.349 and 0.430 for morning, evening and slope cortisol, 
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Table 1 Descriptive statistics of participants by study
CaPS HCS NSHD NCDS
Sample with WEMWBS and cortisol; n 592 1055 1736 5337
Gender; n (%) male 530 (100) 463 (44) 809 (47) 2464 (50)
Age range at cortisol measurement (years); (mean 
(SD))
65–82
(72.8 (4.0))
60–73
(66.6 (2.7))
62–64
(63.6 (0.8))
44–46
(44.1 (0.2))
Age range at WEMWBS assessment (years); 
(mean (SD))
73–90
(80.1 (3.9))
69–78
(73.2 (2.4))
62–64
(63.6 (0.8))
50–51
(50.7 (0.1))
Follow-up time cortisol to WEMWBS assessment 
(years); mean (SD)
7.6 (0.4) 6.6 (1.2) 0 6.6 (0.3)
BMI (kg/m2); mean(SD) 28.2 (3.8) 26.9 (4.2) 27.9 (4.8) 27.1 (4.7)
Adult current smoking status;
n (%) smoker
53 (11.0) 84 (8.1) 160 (10.2) 893 (18.5)
Adult social class; n (%) manual 303 (59.5) 400 (39) 499 (29.2) 1626 (34.1)
WEMWBS score; mean (SD) 53.3 (10.6) 51.7 (8.1) 51.8 (8.0) 49.5 (7.9)
Sampling times (24 hour clock); mean
Waking sample 7:37 N/A 7:11 N/A
Waking+30 mins (+45 min for NCDS) 8:13 7:42 8:11
Waking+3 hour 45 min N/A N/A 11:11
14:00 sample 14:11 N/A N/A
Evening sample 22:00 21:9.27 N/A
Serum cortisol (nmol/L) N/A 258.1 (81.2) N/A N/A
Salivary cortisol (nmol/L)
Early morning; mean (SD) 19.7 (9.5) 22.9 (9.6) 21.3 (10.8)
Night time; median (IQR) 2.3 (1.5, 3.5) 2.4 (1.7,3.7) N/A
Diurnal slope (nmol/L/h); mean (SD) −1.13 (0.7) −1.43 (0.7) −4.3 (3.8)
Cortisol awakening response; mean (SD) 2.3 (9.4) 6.4 (11.7) N/A
Exclusions due to being on corticosteroids; n(%) 62 (10%) 13 (1.2%) 19 (1.1%) 396 (7.5)*
*Endocrine medication.
CaPS, Caerphilly Prospective Study; HCS, Hertfordshire Cohort Study; NCDS, National Child Development Study; NSHD, National Survey of 
Health and Development; WEMWBS, Warwick Edinburgh Mental Wellbeing Scale.
respectively. In addition, because both heightened and 
blunted CAR have been linked to raised disease risk, we 
tested whether well-being differed for those with a CAR in 
the top third or bottom third relative to the middle third.
results
The characteristics of the participants of the four cohorts 
in the analysis are shown in table 1. Age at time of well-
being measurement ranged from mean (SD) age of 50.7 
(0.1) years in NCDS to 80.1 (3.9) years in CaPS. Mean 
well-being ranged from 49.5 (7.9) in NCDS to 53.3 (10.6) 
in CaPS and increased with mean age of the cohort. Mean 
early morning cortisol values were similar for the three 
cohorts (CaPS, NSHD, NCDS) that had measured sali-
vary cortisol. Night-time cortisol values were also similar 
although diurnal slope was more negative (indicating 
greater decline) in NCDS than in NSHD and CaPS.
We found no evidence of an association between early 
morning cortisol and well-being in the individual cohorts 
in sex, age and follow-up time adjusted models. The 
overall pooled estimate was 0.02 (95% CI −0.17 to 0.21; 
p=0.8), and there was no evidence of heterogeneity in this 
association across studies (I2=2.3; p for heterogeneity=0.4) 
(table 2 and figure 1). Further adjustment for all covari-
ates did not affect the overall pooled estimate 0.01 (95% 
CI −0.22 to 0.24; I2=18.0; p for heterogeneity=0.3).
Sex, age and follow-up time adjusted associations 
between evening cortisol and well-being in the indi-
vidual cohorts were in the expected direction (ie, higher 
evening cortisol was associated with lower well-being) in 
NSHD: −0.33 (95% CI −0.77 to 0.11); CaPS −0.98 (95% 
CI −2.03 to 0.07). This indicates a weak inverse associa-
tion between evening cortisol and well-being (table 2 
and figure 2). Adjustment for BMI, smoking and social 
class attenuated this association. Again, there was no 
evidence of heterogeneity across studies (I2=19.1; p for 
heterogeneity =0.3).
In the pooled analysis a flatter diurnal slope was associ-
ated with poorer well-being though this was not statistically 
significant before or after adjustment for all covariates 
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(table 2 and figure 3). Results excluding NCDS (based on 
decline in cortisol between early and late morning) were 
similar (0.02 (95% CI −0.41, 0.46)). In the sex, age and 
follow-up time adjusted and in the fully adjusted models, 
a higher CAR tended to be associated with lower well-
being although the association did not approach statis-
tical significance (table 2 and figure 4).
In sensitivity analysis, correcting for regression dilution 
bias, the sex, age and follow-up time adjusted associations 
between cortisol and well-being were 0.036, –1.347 and 
−0.163 for morning, evening and slope cortisol, respec-
tively. We found no evidence that well-being differed 
according to thirds of the CAR distribution.
dIscussIOn
Based on meta-analysis of individual participant data 
from four large cohort studies, we found that morning 
cortisol, diurnal slope and CAR were not associated with 
well-being, but there was evidence that higher evening 
cortisol was prospectively associated with lower positive 
mental well-being in middle and older age. The magni-
tude of this association was small (−0.06 SD in well-being) 
in crude analysis though up to −0.17 SD in well-being 
accounting for possible regression dilution bias. This asso-
ciation was attenuated by the inclusion of BMI, smoking 
and socioeconomic position. It remains unclear whether 
obesity is secondary to HPA axis dysregulation so this may 
represent overadjustment for a variable on the explana-
tory pathway. Perceived stress is also linked to lower socio-
economic position, smoking and cortisol levels27 30 and so 
isolating an association between cortisol and well-being 
independently of these factors needs to be interpreted 
with caution.
Evening cortisol is arguably the least affected by 
salivary sampling protocol deviations, which can bias 
associations between cortisol and well-being towards 
the null.7 Furthermore, single-day sampling tends to 
bias cortisol estimates towards state rather than trait 
values,31 which may also explain the lack of associa-
tion with well-being up to 8 years later. Only one of the 
included studies captured cortisol profiles on more than 
1 day and this study (ie, CaPS) only sampled cortisol on 
2 days. We note that there was also a trend towards lower 
well-being among those with higher morning cortisol 
in CaPS though this did not attain statistical signifi-
cance. Replication in additional studies with samples 
over multiple days is warranted. We examined interin-
dividual differences in cortisol in relation to well-being 
up to 8 years after assessment of cortisol patterns. It is 
possible that an association between cortisol and well-
being would only be evident over a shorter lag time. 
When measured on the same day, studies have found 
higher positive affect among those with lower cortisol 
output.14 34 35 In addition, lower output in the first 
45 min after waking8 and total output across the day10 
has been associated with higher well-being over a 
period of 3–4 weeks. Where intensive study designs have 
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Figure 1 Meta-analysis of the association between early morning cortisol and well-being (sex and follow-up time adjusted).
Figure 2 Meta-analysis of the association between evening cortisol and well-being (sex and follow-up time 
adjusted). CaPS, Caerphilly Prospective Study;  NSHD, National Survey of Health and Development.
been used to measure intraindividual change based on 
serial measurements of both cortisol and well-being 
repeated over multiple days, some studies find evidence 
of an inverse association between cortisol output and 
positive affect11 13 36–38 though others do not.9 15 16 Trait 
positive affect has been found to predict higher evening 
 o
n
 M
ay 5, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-016085 on 12 October 2017. Downloaded from 
 7Stafford M, et al. BMJ Open 2017;7:e016085. doi:10.1136/bmjopen-2017-016085
Open Access
Figure 3 Meta-analysis of the association between flatter diurnal slope and well-being (sex and follow-up time 
adjusted). CaPS, Caerphilly Prospective Study; National Child Development Study; NSHD, National Survey of Health and 
Development.
Figure 4 Meta-analysis of the association between cortisol awakening response and well-being (sex and follow-up time 
adjusted). CaPS, Caerphilly Prospective Study;  NSHD, National Survey of Health and Development.
cortisol (in men only)39 though we are not aware that 
a prospective association between baseline cortisol and 
subsequent mental well-being has been assessed. Future 
studies are warranted to examine the longitudinal 
association between cortisol sampled over multiple days 
and mental well-being to more accurately capture trait 
cortisol. In addition, cortisol samples taken at regular 
intervals throughout follow-up would enable us to 
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identify how changes in HPA axis activation, such as 
hypocortisolism as a response to chronic stress, might 
be related to mental well-being.
Though the evidence remains inconsistent at present, 
explanatory pathways include the overactivation of the 
HPA axis which interacts with the serotonin system and 
may ultimately result in serotonin depletion, increasing 
proneness to negative emotional states and reducing posi-
tive emotionality.6 40 41 In addition, it has been proposed 
that the energy-mobilising properties of cortisol may 
underlie an association with positive mental well-being 
and that this pathway may be less relevant for under-
standing an association between cortisol and mental ill 
health.7 The evidence base is currently too limited to 
determine whether diurnal cortisol is related to different 
components of positive mental well-being and to negative 
mental health in the same way though there is some indi-
cation that well-being and ill-being do not show the same 
correlations with cortisol slope.10 The current study used 
WEMWBS, designed to capture both hedonic and eudae-
monic well-being over the last 2 weeks. Future research 
might explore a wider set of hedonic and eudaemonic 
components of mental well-being, as well as measures of 
mental ill health, in a single analytical sample to estab-
lish whether they show the same or different relationships 
with diurnal cortisol.
Other limitations should be acknowledged. There were 
differences in the protocol for the collection of cortisol. 
Morning serum cortisol was collected in one study and 
salivary cortisol in the remaining three. Among those 
studies with salivary cortisol, morning average cortisol was 
derived from samples taken at or before the typical peak 
(CaPS and NSHD) but after the typical peak in NCDS, 
and cortisol levels differ considerably during this period.42 
In addition, we excluded participants taking endocrine 
system medication in NCDS in contrast to participants 
on corticosteroid medication in the other studies though 
the former approach is more conservative. Despite these 
differences, we did not find evidence of between-study 
heterogeneity in the estimates from the meta-analysis 
(with all I2 values below 21%). We used clock time but 
cortisol patterns are more closely anchored to waking 
time. Participants were instructed to provide samples at 
specified times postwaking but actual waking time was 
not recorded. In addition, a maximum of four samples 
per day were collected and additional measures may have 
provided more accurate assessment of diurnal cortisol, 
especially diurnal slope. We did not consider factors that 
may modify the prospective association between cortisol 
and well-being, such as social support which has been 
shown to buffer the health impact of stress.43
Nevertheless, the current study also has strengths. It 
includes a large number of participants (ranging from 
1756 to 7515 in each analysis and considerably larger 
than any previous study) in population-based samples, 
using harmonised measures of well-being and covariates. 
Individual participant data meta-analysis was used, which 
has advantages over aggregate meta-analysis including 
greater statistical power and standardisation of the deri-
vation of variables and analytical models.44
In summary, the findings from this meta-analysis do 
not provide support for the hypothesis that cortisol 
profiles indicative of disrupted HPA axis functioning 
have strong associations with positive mental well-being 
in healthy middle-aged and older people. Of the four 
diurnal cortisol levels considered here, only evening 
cortisol showed a prospective association with well-being 
and only in minimally adjusted analysis. However, cortisol 
was sampled on only 1 or 2 days and studies with samples 
across multiple days may find stronger associations if they 
better characterise cortisol patterns, though it seems 
likely that any associations, if found, will be of modest to 
moderate magnitude.
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